DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /QuinazolinesQuinazolines
  6. /M-2698M-2698
Chemical structure of CAS 1379545-95-5

M-2698

In Stock•Starting at $48 for 1 mg•Purity ≥ 98%
CAS No.1379545-95-5
MDL No.N/A
MFC21H19ClF3N5O
MW449.90
InChI KeyHXAUJHZZPCBFPN-QGZVFWFLSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98+%$48In Stock
5 mg98%$131In Stock
10 mg98%$221In Stock
25 mg98%$517In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1379545-95-5
Product NameM-2698

Biological Targets

RPS6KB2·RPS6KB1·AKT1·AKT3

Associated Conditions

neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.

Journal of hematology & oncology • Vol. 14, Issue 1 • 2021
PMID: 34407844PMC: PMC8371902DOI: 10.1186/s13045-021-01132-z

M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier.

American journal of cancer research • Vol. 6, Issue 4 • 2016
PMID: 27186432PMC: PMC4859885

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact